Medical Condition News

RSS

Phase I study of selumetinib drug shows partial response in pediatric neural tumors

In an early-phase clinical trial of a new oral drug, selumetinib, children with the common genetic disorder neurofibromatosis type 1 (NF1) and plexiform neurofibromas, tumors of the peripheral nerves, tolerated selumetinib and, in most cases, responded to it with tumor shrinkage.

29 Dec 2016

Welders can develop Parkinson's disease-like symptoms that get worse with exposure

Welders can develop Parkinson's disease-like symptoms that may get worse the longer and more they are exposed to the chemical element manganese from welding fumes, according to a study published in the December 28, 2016, online issue of Neurology®, the medical journal of the American Academy of Neurology.

29 Dec 2016

Super-resolution fluorescence microscopy sheds light on brain’s molecular mechanism

Advances in microscopy techniques have often triggered important discoveries in the field of neuroscience, enabling vital insights in understanding the brain and promising new treatments for neurodegenerative diseases such as Alzheimer's and Parkinson's.

29 Dec 2016

Fred Hutch’s new Evergreen Fund to promote commercialization of research into lifesaving therapies

Fred Hutchinson Cancer Research Center announced its first-ever grants from its newly established Evergreen Fund to spur researchers' efforts to advance bold ideas toward creating or partnering with a commercial entity.

28 Dec 2016

Critical illness events linked to delayed discharge from hospital for neighboring patients

In a research letter published Dec. 27, 2016, in JAMA, University of Chicago physicians describe a new concern for patients in the hospital: distractions caused by the misfortune of other patients.

28 Dec 2016

FDA grants permission to assess safety of investigational drug for Alzheimer's disease in humans

Vanderbilt University scientists have received notification from the U.S. Food and Drug Administration that testing in humans may proceed for an investigational new drug for Alzheimer's disease after more than 10 years of research by scientists at Vanderbilt University and Vanderbilt University Medical Center.

28 Dec 2016

Research highlights need to improve sleep for homeless people

The homeless sleep less and are more likely to have insomnia and daytime fatigue than people in the general population, findings researchers believe suggest more attention needs to be paid to improving sleep for this vulnerable population, according to a research letter published online by JAMA Internal Medicine.

28 Dec 2016

'Friendship Bench' approach holds potential to improve lives of people with mental health problems

Their offices are simple wooden seats, called Friendship Benches, located in the grounds of health clinics around Harare and other major cities in Zimbabwe.

28 Dec 2016

New comprehensive study lists top personal health expenses in the U.S.

Just 20 conditions make up more than half of all spending on health care in the United States, according to a new comprehensive financial analysis that examines spending by diseases and injuries.

28 Dec 2016

Scientists report new molecular mechanism that could be cause of autoimmune diseases

Scientists at the Immunology Frontier Research Center (IFReC), Osaka University, Japan, report a new molecular mechanism that could explain the cause of some autoimmune diseases.

27 Dec 2016

Researchers move closer to understanding neural basis of facial identification

At a glance, you can recognize a friend's face whether they are happy or sad or even if you haven't seen them in a decade. How does the brain do this -- recognize familiar faces with efficiency and ease despite extensive variation in how they appear?

27 Dec 2016

Kessler Foundation researcher receives grant to identify treatments for cognitive deficits in people with SCI

The three-year federal grant will fund research to identify treatments for cognitive difficulties in persons with spinal cord injury.

27 Dec 2016

Novel mathematical model could help provide causes of complex multifactorial diseases

Patients with complex diseases have a higher risk of developing another. Multi-morbidity represents a huge problem in everyday clinical practice, because it makes it more difficult to provide successful treatment.

27 Dec 2016

Combination of diabetes and hypertension drugs can effectively treat cancer

A combination of a diabetes medication and an antihypertensive drug can effectively combat cancer cells.

27 Dec 2016

Scientists identify sugar molecule that reduces inflammatory response and COPD progression

Using a mouse model, scientists from the RIKEN-Max Planck Joint Research Center for Systems Chemical Biology and a number of other institutes have identified a sugar molecule that reduced the inflammatory response and progress of emphysema, a common component of chronic obstructive pulmonary disease (COPD).

27 Dec 2016

Medical Condition News

Phase I study of selumetinib drug shows partial response in pediatric neural tumors

Welders can develop Parkinson's disease-like symptoms that get worse with exposure

Super-resolution fluorescence microscopy sheds light on brain’s molecular mechanism

Fred Hutch’s new Evergreen Fund to promote commercialization of research into lifesaving therapies

Critical illness events linked to delayed discharge from hospital for neighboring patients

FDA grants permission to assess safety of investigational drug for Alzheimer's disease in humans

Research highlights need to improve sleep for homeless people

'Friendship Bench' approach holds potential to improve lives of people with mental health problems

New comprehensive study lists top personal health expenses in the U.S.

Scientists report new molecular mechanism that could be cause of autoimmune diseases

Researchers move closer to understanding neural basis of facial identification

Kessler Foundation researcher receives grant to identify treatments for cognitive deficits in people with SCI

Novel mathematical model could help provide causes of complex multifactorial diseases

Combination of diabetes and hypertension drugs can effectively treat cancer

Scientists identify sugar molecule that reduces inflammatory response and COPD progression

Reduced radiation can maintain high cure rates in patients with HPV-related oropharyngeal cancers

Whitehead Institute researchers identify mechanism underlying cancer drug-resistance

ACA financial penalties lead to reductions in hospital readmission rates for common conditions

Nanodiscs deliver customized therapeutic vaccine for treatment of colon, melanoma cancers

New findings about key cellular protein could lead to treatments for neurodegenerative diseases

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News